Medicine & Life Sciences
Patient Reported Outcome Measures
100%
Neoplasms
59%
Breast Neoplasms
54%
Trastuzumab
52%
Quality of Life
38%
Terminology
37%
Primary Myelofibrosis
33%
Clinical Trials
33%
Polycythemia Vera
31%
Therapeutics
25%
Lapatinib
23%
human ERBB2 protein
21%
National Cancer Institute (U.S.)
20%
INCB018424
19%
Essential Thrombocythemia
19%
Survival
17%
Drug Therapy
16%
Disease-Free Survival
14%
Fatigue
14%
Randomized Controlled Trials
14%
Symptom Assessment
13%
Apolipoprotein E4
12%
Research Personnel
12%
Melanoma
11%
palbociclib
11%
Prostatic Neoplasms
10%
Confidence Intervals
10%
Cognitive Dysfunction
10%
Mastectomy
10%
Lenalidomide
9%
Breast
9%
Recurrence
8%
Progression-Free Survival
8%
Pain
8%
Cognitive Aging
8%
Memory
7%
Hydroxyurea
7%
Glioblastoma
7%
RG7388
7%
Alzheimer Disease
7%
Multiple Myeloma
6%
Triple Negative Breast Neoplasms
6%
Cyclophosphamide
6%
Glioma
6%
Dexamethasone
6%
Sentinel Lymph Node Biopsy
6%
Medical Oncology
6%
Carpal Tunnel Syndrome
6%
Biopsy
6%
Cerebral Blood Volume
6%